骨骼密度強度 | Bone Density & Strength
如你有此疾病,請遵照閣下醫生的完整醫療方案;而是否使用多學科復康方案前,你必須咨詢主診醫生的意見,如果閣下的主診醫生不建議您加入補充劑調理組合,請你不要使用。如果你需要尋求其他醫生作第二咨詢,閣下可聯絡我們線上<無邊界醫生>或你自己城市內的其他專業醫生的再診斷。
骨質疏鬆症
骨質疏鬆症的病因包括缺乏體力活動、營養不良、潜在疾病、藥物攝入和不可改變的因素，如年齡、性別和熟悉的易感性。充分預防或治療骨質疏鬆症是個人和公眾健康的一個非常重要的目標，因為骨質疏鬆性骨折是造成老年人慢性疼痛、不活動和殘疾的原因。據估計，在世界範圍內，每三分之一的女性和五分之一的50歲以上的男性會因骨質疏鬆導致骨折[1]。現時，骨質疏鬆症的防治有多種治療方法。非藥理學方法，如日常體育活動、戒烟和减少飲酒，是維持骨骼健康的重要輔助因素。此外，在骨質疏鬆症的治療中，建議補充鈣和維他命D，但尚未證明能顯著降低骨折風險。藥物治療包括雙膦酸鹽、人單克隆抗躰治療和選擇性雌激素受體調節劑等物質。雙膦酸鹽是最廣泛使用的藥物，並被指定為“金標準”抗分解代謝治療骨折預防。
If you have this disease, please follow your doctor's complete medical plan. You must consult the attending doctor before using the multidisciplinary rehabilitation plan. If your attending doctor does not recommend you to join the supplement conditioning combination, please do not use it. If you need to seek second consultation from other doctors, you can contact our online "Doctors Without Borders", or another professional doctor in your own city.
Osteoporosis
The etiology of osteoporosis includes a lack of physical activity, malnutrition, underlying diseases, drug ingestion and non-modifiable factors, such as ageing, gender, and familiar predisposition. Adequate prevention or therapy of osteoporosis is a very important goal for individual and public health, because osteoporotic bone fractures are responsible for chronic pain, inactivity and invalidity in the elderly. It is estimated that, worldwide, every third women, and one in five men over the age of 50, will sustain an osteoporotic-induced bone fracture [1]. At present, there are a number of therapeutic approaches for the prevention and treatment of osteoporosis. Non-pharmacological approaches, such as daily physical activity, smoking cessation and reduction of alcohol consumption, are very important cofactors in maintaining bone health. In addition, supplementation with calcium and vitamin D is recommended in osteoporosis management, but has not been shown to significantly reduce bone fracture risk. Pharmacological treatment includes substances such as bisphosphonates, human monoclonal antibody therapy and selective estrogen receptor modulators. Bisphosphonates are the most widely-used medication and are designated as the “gold standard” anti-catabolic therapy in fracture prophylaxis.
